Literature DB >> 1757563

Evaluation of a new method for identification of Cryptococcus neoformans which uses serologic tests aided by selected biological tests.

K Kabasawa1, H Itagaki, R Ikeda, T Shinoda, K Kagaya, Y Fukazawa.   

Abstract

A new method for identifying Cryptococcus neoformans isolates and their serotypes by the slide agglutination test using five kinds of factor sera, with the aid of nitrate reduction, phenol oxidase, and growth at 37 degrees C tests was evaluated by using 36 reference strains and 75 clinical isolates of C. neoformans. The results showed that the reference strains were identified exactly as they were labeled, and clinical isolates were identified as C. neoformans serotypes A, D, and AD. C. neoformans could be distinguished from other Cryptococcus species that cross-reacted with factor sera by their ability to grow at 37 degrees C. These results indicate that the slide agglutination test combined the use of factor sera for isolates which grow at 37 degrees C is a useful method for identification of C. neoformans and their serotypes and that the nitrate reduction test (negative in 100% of the isolates) and the phenol oxidase test (positive in approximately 95% of the isolates) can be used to confirm that the species is C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1757563      PMCID: PMC270451          DOI: 10.1128/jcm.29.12.2873-2876.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Evaluation of the updated Vitek yeast identification data base.

Authors:  M el-Zaatari; L Pasarell; M R McGinnis; J Buckner; G A Land; I F Salkin
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

Review 2.  Pathology of the mycoses in patients with the acquired immunodeficiency syndrome (AIDS).

Authors:  F W Chandler
Journal:  Curr Top Med Mycol       Date:  1985

3.  Cryptococcus albidus meningitis.

Authors:  J C Melo; S Srinivasan; M L Scott; M J Raff
Journal:  J Infect       Date:  1980-03       Impact factor: 6.072

4.  Disseminated infection caused by urease-negative Cryptococcus neoformans.

Authors:  P J Ruane; L J Walker; W L George
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

5.  Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C).

Authors:  K J Kwon-Chung; I Polacheck; J E Bennett
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

6.  Six-hour pigmentation test for the identification of Cryptococcus neoformans.

Authors:  R L Hopfer; D Gröschel
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

7.  Comparison of the Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical yeast isolates.

Authors:  M A Pfaller; T Preston; M Bale; F P Koontz; B A Body
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.

Authors:  R Ikeda; T Shinoda; Y Fukazawa; L Kaufman
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

  8 in total
  19 in total

1.  Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents.

Authors:  N Poonwan; Y Mikami; S Poosuwan; J Boon-Long; N Mekha; M Kusum; K Yazawa; R Tanaka; K Nishimura; K Konyama
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

2.  Production of agglutinating monoclonal antibody against antigen 8 specific for Cryptococcus neoformans serotype D.

Authors:  R Ikeda; S Nishimura; A Nishikawa; T Shinoda
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.

Authors:  J Xu; C Onyewu; H J Yoell; R Y Ali; R J Vilgalys; T G Mitchell
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  First identification of autochthonous Cryptococcus neoformans var. gattii isloated from goats with predominantly severe pulmonary disease in Spain.

Authors:  T Baró; J M Torres-Rodríguez; M H De Mendoza; Y Morera; C Alía
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Cryptococcosis in a bottlenose dolphin (Tursiops truncatus) caused by Cryptococcus neoformans var. gattii.

Authors:  W George Miller; Arvind A Padhye; William van Bonn; Eric Jensen; Mary E Brandt; Sam H Ridgway
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  Geographic distribution of mating type alleles of Cryptococcus neoformans in four areas of the United States.

Authors:  Zhun Yan; Xiaogang Li; Jianping Xu
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 7.  Microreview: capsule-associated genes of Cryptococcus neoformans.

Authors:  Ken Okabayashi; Atsuhiko Hasegawa; Toshi Watanabe
Journal:  Mycopathologia       Date:  2007-01       Impact factor: 2.574

8.  Origin of Cryptococcus neoformans var. neoformans diploid strains.

Authors:  M Cogliati; M C Esposto; D L Clarke; B L Wickes; M A Viviani
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

9.  Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide.

Authors:  F Dromer; E Gueho; O Ronin; B Dupont
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

10.  Multilocus enzyme typing of Cryptococcus neoformans.

Authors:  M E Brandt; S L Bragg; R W Pinner
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.